Source: Clinical and Developmental Immunology. Unidade: FMRP
Subjects: VACINAS (ADMINISTRAÇÃO E DOSAGEM), ENCEFALOMIELITE ANIMAL (IMUNOLOGIA), DOENÇAS AUTOIMUNES, INTERFERONS, TUBERCULOSE (PREVENÇÃO E CONTROLE)
ABNT
ZORZELLA-PEZAVENTO, Sofia Fernanda Gonçalves et al. BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis. Clinical and Developmental Immunology, v. 2013, 2013Tradução . . Disponível em: https://doi.org/10.1155/2013/721383. Acesso em: 19 nov. 2024.APA
Zorzella-Pezavento, S. F. G., Guerino, C. P. F., Chiuso-Minicucci, F., França, T. G. D., Ishikawa, L. L. W., Masson, A. P., et al. (2013). BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis. Clinical and Developmental Immunology, 2013. doi:10.1155/2013/721383NLM
Zorzella-Pezavento SFG, Guerino CPF, Chiuso-Minicucci F, França TGD, Ishikawa LLW, Masson AP, Silva CL, Sartori A. BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis [Internet]. Clinical and Developmental Immunology. 2013 ; 2013[citado 2024 nov. 19 ] Available from: https://doi.org/10.1155/2013/721383Vancouver
Zorzella-Pezavento SFG, Guerino CPF, Chiuso-Minicucci F, França TGD, Ishikawa LLW, Masson AP, Silva CL, Sartori A. BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis [Internet]. Clinical and Developmental Immunology. 2013 ; 2013[citado 2024 nov. 19 ] Available from: https://doi.org/10.1155/2013/721383